This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

This study has been completed.
Sponsor:
Collaborators:
Baxter BioScience
National Institutes of Health (NIH)
Information provided by:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00299988
First received: March 3, 2006
Last updated: November 8, 2010
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)